VINC Vincerx Pharma
- 0.659
- -0.025-3.63%
- 0.650
- -0.009-1.37%
Vincerx Pharma News
Vincerx Pharma Q1 EPS $(0.58) Misses $(0.29) Estimate
Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.29) by 100 percent. This is a 14.71 percent increase over losses of $(0.6
Vincerx Pharma | 10-Q: Quarterly report
Vincerx Pharma: Recent Financing Provides Expected Cash Runway Through 2024 >VINC
Vincerx Pharma: Recent Financing Provides Expected Cash Runway Through 2024 >VINC
Vincerx Pharma 1Q Loss/Shr 58c >VINC
Vincerx Pharma 1Q Loss/Shr 58c >VINC
Press Release: Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Vincerx Pharma, Inc. (Nasdaq: VINC), today reported financial results for the first quarter of 2024 and provided a corporate update.
Vincerx Pharma Shares Are Trading Higher, Reversing From Earlier Weakness After the Company Announced a Proposed Underwritten Public Offering of Common Stock and Warrants.
Vincerx Pharma Shares Are Trading Higher, Reversing From Earlier Weakness After the Company Announced a Proposed Underwritten Public Offering of Common Stock and Warrants.
Why Vincerx Pharma (VINC) Stock Is Falling
Vincerx Pharma Inc (NASDAQ:VINC) shares are trading lower by 9.7% to $0.81 during Friday's session after the company priced an underwritten public offering, including 6 million shares of common stock
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i
Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.8% and the actively traded Invesco QQQ Trust (QQQ) was 1.1% higher in Friday's premarket activity, boosted by a rally in tec
Vincerx Pharma Prices Public Offering of Shares, Warrants
Vincerx Pharma (VINC) shares were down more than 16% premarket Friday after the company priced an underwritten public offering of 6 million common shares and accompanying warrants to purchase 6 millio
Vincerx Pharma Dips 16%, Prices $16M Stock
Vincerx Pharma Expects Offering to Close on or About April 30 >VINC
Vincerx Pharma Expects Offering to Close on or About April 30 >VINC
Press Release: Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 51.8% to $1.29 during Thursday's after-market session. The company's market cap stands at $212.3 million. Fresh2 Group (NASDAQ:FRES) stock rose 10
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stk and Warrants >VINC
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stk and Warrants >VINC
Vincerx Pharma Inc (VINC) Gets a Buy From Leerink Partners
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cash flow for the full fiscal year 2024.
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
On Monday, Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research Annual Meeting 2024.VNC-236-1
Analysis
Price Target
No Data
